Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
dental caries/diare
Tautan disimpan ke clipboard
11 hasil
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a .sctn. 371 of International Application No. PCT/IB2015/056905, filed 9 Sep. 2015, which claims the priority of PCT/CN2015/086995, filed 14 Aug. 2015, and PCT/CN2014/086197, filed 10 Sep. 2014, which are incorporated herein in their entireties.
FIELD OF INVENTION
This invention
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a .sctn.371 of International Application No. PCT/CN2015/089332, filed 10 Sep. 2015, which claims the priority of PCT/CN2014/000834, filed 10 Sep. 2014, which are incorporated herein in their entireties.
FIELD OF INVENTION
This invention relates to novel compounds which are
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Compounds as rearranged during transfection (RET) inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF INVENTION
This invention relates to novel compounds which are inhibitors of the Rearranged during Transfection (RET) kinase, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy, alone or in combination, for the normalization of
Pyridine derivatives as rearranged during transfection (RET) kinase inhibitors
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a 371 of International Application No. PCT/IB2014/059817, filed 14 Mar. 2014, which claims priority of PCT/CN2014/072449, filed 24 Feb. 2014; PCT/CN2013/090059, filed 20 Dec. 2013; and PCT/CN2013/072683, filed 15 Mar. 2013.
FIELD OF INVENTION
This invention relates to novel
Par-2-activating peptide derivative and pharmaceutical composition using the same
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to a peptide derivative with a PAR-2-activating action or a salt thereof, and a pharmaceutical composition comprising the same as the effective ingredient. More specifically, the invention relates to a PAR-2-activating agent. Still more
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
